Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry 17 January 20246 November 2023 by dfischer
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF 17 January 202421 September 2021 by dfischer
Predictors of sudden cardiac death in high-risk patients following a myocardial infarction 17 January 202416 January 2020 by dfischer
Predictors of sudden cardiac death in high-risk patients following a myocardial infarction 17 January 202416 January 2020 by dfischer
Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death in the real world: Main findings from the French multicentre DAI-PP programme (pilot phase) 27 June 202327 August 2019 by pp-digitalszene
Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction 27 June 20231 July 2018 by pp-digitalszene
Devices for management of sudden cardiac death: Successes, challenges and perspectives 27 June 202315 March 2017 by pp-digitalszene
Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: From the Israeli ICD Registry 27 June 202313 August 2015 by pp-digitalszene
Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death? 27 June 20233 May 2013 by pp-digitalszene
